Results 131 to 140 of about 11,382 (203)

CD5 Expression in CTCL and Its Implications for Anti-CD5 CAR T-Cell Therapy. [PDF]

Int J Mol Sci
Wardeh L, Williams M, Prestwood C, Wolner Z, Nikbakht N.   +4 more
europepmc   +1 more source

Extracorporeal photopheresis therapy rapidly changes the cytokine profile and tumor microenvironment in cutaneous T cell lymphoma. [PDF]

Front Immunol
Melchers S, Tengler L, Şener ÖÇ, Beltzig PL, Schmidt R, Klein S, Utikal JS, Nicolay JP.   +7 more
europepmc   +1 more source

An Update on Single-Cell RNA Sequencing in Illuminating Disease Mechanisms of Cutaneous T-Cell Lymphoma. [PDF]

Cancers (Basel)
Suhl S, Kaminsky A, Chen C, Lapolla BA, Zhou MH, Kent J, Marx A, Nebo ID, Ramush G, Luyten S, Sacknovitz Y, Sung J, Bear CM, Schreidah CM, Gru A, Geskin LJ.   +15 more
europepmc   +1 more source

Cutaneous Lymphoma Associated with JAK Inhibitors: A Pharmacovigilance Analysis of the FAERS Database and Literature Review. [PDF]

Acta Derm Venereol
Lu L, Feng J, He H, Peng Y, Zhang S, Yang L, Liu Y, Wang T.   +7 more
europepmc   +1 more source

Hydrochlorothiazide-associated cutaneous pseudolymphoma. [PDF]

JAAD Case Rep
Chavez M, Goldenberg A, Kuraitis D.
europepmc   +1 more source

Retrospective Analysis of Second Primary Malignancies in Patients with Mycosis Fungoides and Sézary Syndrome in Croatia. [PDF]

Dermatol Pract Concept
Petkovic M, Ilic I, Ceovic R.
europepmc   +1 more source

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015 [PDF]

, 2016
Abel EA, Berg M, Berg M, Bhatnagar A, Bilsland D, Bjellerup M, Calzavara‐Pinton PG, Chen X, Cox AJ, Deleu H, Diffey BL, Freeman K, George SA, Gilchrest BA, Grattan CE, Hannuksela M, Hönigsmann H, Jansén CT, Jansén CT, Jeanmougin M, Joint Formulary Committee, Kao CL, Kivanc MT, Lassus A, Leonard F, LeVine MJ, Lindelöf B, Maravić N, Margolis D, Marguery MC, Marsland AM, Mastalier U, Mathews‐Roth MM, McFadden N, McGeorge BC, Molin L, Morison WL, Neumann NJ, Norris PG, Park YM, Pirner K, Pothiawala SZ, Reymond JL, Roelandts R, Roelandts R, Roelandts R, Roenigk HH, Ros AM, Ros AM, Rosén K, Rosén K, Rosén K, Rübben A, Sheehan‐Dare RA, Stadler R, Stern RS, Takashima A, Tegner E, Tegner E, Thomsen K, Turjanmaa K, Viander M, Vázquez‐López F, Weelden H, Wennersten G, Wilkinson JD   +65 more
core   +2 more sources

Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma. [PDF]

NAR Cancer
Shimauchi T, Murai J, Iwasaki M, Phadungsaksawasdi P, Ojima T, Fujii K, Honda T.   +6 more
europepmc   +1 more source

Divergent Evolution of Malignant Subclones Maintains a Balance between Induced Aggressiveness and Intrinsic Drug Resistance in T-cell Cancer. [PDF]

Cancer Discov
Buus TB, Vadivel CK, Gluud M, Namini MRJ, Zeng Z, Hedebo S, Yin M, Willerslev-Olsen A, Pallesen EMH, Yan L, Blümel EP, Ewing EU, Ahmad S, Sorrosal LP, Geisler C, Bonefeld CM, Woetmann A, Andersen MH, Mustelin T, Johansen C, Wobser M, Kamstrup MR, Guenova E, Becker JC, Koralov SB, Bech R, Ødum N.   +26 more
europepmc   +1 more source

Use of Extracorporeal Photopheresis Treatment Over Time (2001-2023) in Alberta, Canada: A Retrospective Cohort Study. [PDF]

Health Sci Rep
Girard L, Aponte-Hao S, Randall JR, Martins KJB, Luu H, Vu K, Williamson T, Klarenbach SW.   +7 more
europepmc   +1 more source